SARS-CoV-2 in CorrectionalPopulations:A collaborative, ethical approach to application of wastewater-based surveillance
Project Number1U01DA056000-01
Former Number1U01AG077377-01
Contact PI/Project LeaderSPAULDING, ANNE C
Awardee OrganizationEMORY UNIVERSITY
Description
Abstract Text
Throughout the COVID19 pandemic in the U.S., persons in jails have borne a share of disease 3-fold or greater
than that seen in the general population. While many cases have been imported from surrounding communities,
crowding in these congregate settings has led to rapid in-house transmission, especially since testing in jails has
been sparse. Vaccine hesitancy among staff and those detained mean the population is ill prepared for new waves
of infection, perhaps from virus variants. Better surveillance could warn systems earlier, and allow jails to stem
the tide of a new outbreak. At least half, if not more, of infected persons shed coronavirus in their stool.
Monitoring wastewater is a promising practice that only a few jails have adopted. Our overarching goal is to
introduce or refine Wastewater Based Surveillance (WBS) as an evidence-based strategy for SARS-CoV-2
surveillance in the jails of Atlanta, Chicago, suburban Boston and Washington DC. We will adapt it to the needs
of jail settings and evaluate the implementation with the Consolidated Framework for Implementation Research.
Implementation teams will be formed of both correctional staff and formerly incarcerated individuals. Our aims:
(1) To assess the barriers to and facilitators of implementing WBS for SARS-CoV-2 detection in 4 jail
demonstration sites. Guided by CFIR, we hold an informational webinar, then conduct focus groups. Four will
be with leaders at each of the jails; these will discuss the site-specific context in which WBS will be introduced or
refined. A fifth, cross-site focus group of jail workers, and a sixth, cross-site group of persons with lived jail
experience, will reflect on characteristics of WBS approaches and implementation strategies in jail settings.
(2) To measure implementation outcomes associated with WBS and use these outcomes to inform key
stakeholders, using a knowledge to action framework. We will study uptake, acceptability, appropriateness and
feasibility of WBS as a sensitive early warning system and a way of quantifying SARS-CoV-2 levels to monitor
trends in COVID19 prevalence. Feasibility, the suitability of how WBS dataare acted upon, will be of utmost
importance. We will use the Knowledge to Action process model, leveraging implementation outcomes to further
engage stakeholders and characterize the adaptions needed to successfully implement WBS in jails.
(3, Pilot) To study the process and the perceived effectiveness of incorporating diverse stakeholders, including
the formerly incarcerated, on the WBS implementation team. We will use the Research Engagement Survey Tool
(REST), to survey early in the implementation process and eight months later, individuals on the implementation
team who have lived experience in jail; all other consenting implementation team members will be surveyed once
early in the implementation process.
Successfully completing the aims will determine factors that promote WBS implementation to improve disease
monitoring in jails. By including persons recently released from jail on the implementation teams, we hope to
inform researchers and policy makers about the ethics and process of collaboration in implementation.
Public Health Relevance Statement
Project Narrative
The U.S. response to the COVID-19 pandemic underscores that structural racism and discrimination affect the
health of Americans; disproportional minority confinement is one of the most overt structural processes that
have blocked access to infectious disease testing for vulnerable individuals. Wastewater-based coronavirus
surveillance in jails can provide a method of monitoring for new SARS-CoV-2 outbreaks that will address
structural impediments blocking equitable access to testing. We hypothesize that including persons with lived
experience in jail on an implementation team to roll out this new technology will help ensure that the data it
produces are used, and in ways which improve the health of those meant to benefit from it.
No Sub Projects information available for 1U01DA056000-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1U01DA056000-01
Patents
No Patents information available for 1U01DA056000-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1U01DA056000-01
Clinical Studies
No Clinical Studies information available for 1U01DA056000-01
News and More
Related News Releases
No news release information available for 1U01DA056000-01
History
No Historical information available for 1U01DA056000-01
Similar Projects
No Similar Projects information available for 1U01DA056000-01